Meta-Analysis on Garlic and Cholesterol Management
Findings from the "most comprehensive" meta-analysis on garlic and blood lipids.
Because conflicting data exists, Australian researchers have finished what they say is the most comprehensive meta-analysis of studies on garlic (Allium sativum) and cholesterol management.
Researchers from the University of Adelaide gathered data from 39 garlic trials on subjects with high cholesterol. Studies measured for changes in total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides. When garlic preparations were consumed for more than two months daily, subjects experienced significant reductions in total cholesterol (17 +/-6 mg/dL) and LDL cholesterol (9 +/-6 mg/dL). Such improvements, according to the researchers, can be associated with a 38% reduced risk of serious cardiovascular events at 50 years of age.
Tolerability of garlic products was high across all studies, suggesting that garlic can be a safe alternative to conventional cholesterol-lowering medications for those with slightly high cholesterol.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.
Recent review makes the case for testing omega-3 fatty acid levels in humans
May 23rd 2024The article commissioned by The Global Organization for EPA and DHA Omega-3s (GOED) reviewed the state of omega-3 fatty acid testing, highlighting the value of testing and the commercially available options for diagnostic testing.
Epax launches concentrated oil that combines omegas 3, 9, and 11
May 10th 2024The blend of long-chain polyunsaturated fatty acids and long-chain monounsaturated fatty acids combines the heart and brain health benefits of omegas-3s with the skin and metabolic health benefits of omegas 9 and 11.
